JP Morgan Chase
GH icon

JP Morgan Chase’s Guardant Health GH Stock Holding History

JP Morgan Chase’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,700
Closed -$998K – 6897
2022
Q4 		$998K Sell
36,700
-3,900
-10% -$178K ﹤0.01% 4037
2022
Q3 		$2.19M Buy
+40,600
New +$2.08M ﹤0.01% 3393
2019
Q2 		– Sell
-10,200
Closed -$782K – 5842
2019
Q1 		$782K Buy
+10,200
New +$565K ﹤0.01% 3953

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

JP Morgan Chase's GH Position: Q2 2026 in Review

JP Morgan Chase increased its Guardant Health (GH) stake by 80% in Q2 2026, buying an estimated $26.6M and bringing the position to 549,088 shares worth $85.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

JP Morgan Chase first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $126M in Q3 2019. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • JP Morgan Chase held 549,088 shares of Guardant Health worth $85.3M as of Q2 2026.
  • JP Morgan Chase bought 244,771 Guardant Health shares in Q2 2026, an estimated $26.6M.
  • Guardant Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1152 holding.
  • JP Morgan Chase first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Guardant Health position peaked at $126M in Q3 2019.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.